Details of the Drug

General Information of Drug (ID: DML99RA)

Drug Name

GSK-2302032A

Synonyms

PRAME ASCI (NSCLC), GSK; Recombinant preferentially expressed antigen of melanoma immunotherapeutic vaccine (non-small cell lung cancer), GlaxoSmithKline

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0B2HC

References

1	ClinicalTrials.gov (NCT01149343) Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer. U.S. National Institutes of Health.